lansoprazole has been researched along with Immune System Diseases in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Immune System Diseases: Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kosukegawa, I | 1 |
| Okazaki, S | 1 |
| Yamamoto, M | 1 |
| Nagoya, S | 1 |
| Suzuki, C | 1 |
| Shimizu, J | 1 |
| Takahashi, H | 1 |
| Yamashita, T | 1 |
1 other study available for lansoprazole and Immune System Diseases
| Article | Year |
|---|---|
The proton pump inhibitor, lansoprazole, prevents the development of non-traumatic osteonecrosis of the femoral head: an experimental and prospective clinical trial.
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Female; Femur He | 2020 |